This was demonstrated by results showing that silencing RIP1 alone induced apoptosis in resistant melanoma cells generated by prolonged exposure to PLX4720 in vitro and in fresh melanoma isolates from patients post-treatment with vemurafenib. Here, RIPK1 is linked to melanoma.